A Sacrococcygeal Teratoma (SCT) is a rare medical miracle that occurs in newborn babies, usually in the first month of life. It is an abnormal growth that develops in the area of the baby’s tailbone. It is most often benign, meaning it is non-cancerous, but can also be malignant, or cancerous. In either case, it is a medical emergency that requires immediate attention. SCTs are classified as either type 1 or type 2. Type 1 SCTs are typically benign and occur in the lower portion of the tailbone. Type 2 SCTs are more likely to be malignant and occur higher up in the tailbone. Both types can cause serious health problems for the baby, including breathing difficulties, developmental delays, and even death.
The exact cause of SCT is unknown, but it is believed to be related to genetic factors. It is also thought that environmental factors, such as exposure to certain chemicals or radiation, may play a role.
SCTs are diagnosed through a physical exam and imaging tests such as ultrasound or magnetic resonance imaging (MRI). Treatment depends on the size and type of the tumor, as well as the age and overall health of the baby. For type 1 SCTs, the tumor is usually surgically removed. In some cases, chemotherapy or radiation may be used to shrink the tumor before surgery. For type 2 SCTs, the tumor may be treated with chemotherapy or radiation, or the entire tumor may be surgically removed.
The outlook for babies with SCTs is generally good. With prompt diagnosis and treatment, most babies make a full recovery. However, there is a risk of complications, including infection, bleeding, and organ damage. In some cases, the tumor may recur or spread to other parts of the body.
A Sacrococcygeal Teratoma is a rare medical miracle that can occur in newborn babies. It is classified as either type 1 or type 2, with type 1 being the more common and benign form. Diagnosis and treatment depend on the size and type of the tumor, as well as the age and overall health of the baby. With prompt diagnosis and treatment, most babies make a full recovery, although there is a risk of complications.
1.
Radiation therapy for patients with breast cancer
2.
Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?
3.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
4.
In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.
5.
Researchers find distinct cell receptors with the potential for new treatments.
1.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
2.
An Overview Of Serum Osmolality: What Is It And How Can It Help You?
3.
Understanding the Importance of Knowing Your MCV Normal Range
4.
Exploring The Causes and Consequences of Low Transferrin Saturation
5.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
4.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation